R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
Rui Su(University of Cincinnati), Lei Dong(University of Cincinnati), Chenying Li(First Affiliated Hospital Zhejiang University), Sigrid Nachtergaele(Howard Hughes Medical Institute), Mark Wunderlich(Cincinnati Children's Hospital Medical Center), Ying Qing(University of Cincinnati), Xiaolan Deng(University of Cincinnati), Yungui Wang(First Affiliated Hospital Zhejiang University), Xiaocheng Weng(Howard Hughes Medical Institute), Chao Hu(First Affiliated Hospital Zhejiang University), Mengxia Yu(First Affiliated Hospital Zhejiang University), Jennifer R. Skibbe(University of Cincinnati), Qing Dai(Howard Hughes Medical Institute), Dongling Zou(Chongqing Cancer Hospital), Tong Wu(Howard Hughes Medical Institute), Kang‐Kang Yu(Howard Hughes Medical Institute), Hengyou Weng(University of Cincinnati), Huilin Huang(University of Cincinnati), Kyle Ferchen(University of Cincinnati), Xi Qin(University of Cincinnati), Bin Zhang(City of Hope), Jun Qi(Harvard University), Atsuo T. Sasaki(University of Cincinnati), David R. Plas(University of Cincinnati), James E. Bradner(Harvard University), Minjie Wei(China Medical University), Guido Marcucci(City of Hope), Xi Jiang(University of Cincinnati), James C. Mulloy(Cincinnati Children's Hospital Medical Center), Jie Jin(First Affiliated Hospital Zhejiang University), Chuan He(Howard Hughes Medical Institute), Jianjun Chen(City of Hope)
Cited by 1,184Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis